Journal of Pharmacy and Pharmacology · 2021 · 31 citations · 21 references
Veterinary MedicineImmunologyPathobiologyInflammationInnate ImmunitySepsisCytokine BiologyCytokine-mediated PathologyInflammatory SignalingMacrophage BiologySepsis PathophysiologyM2-like Macrophage ActivationMacrophage PolarizationMacrophage-driven Tissue InjuryMacrophage-mediated InflammationMacrophage-mediated InjuryMacrophage-mediated Tissue InjurySepsis-associated InflammationSepsis-induced Tissue Injury
OBJECTIVES: To explore the impacts of cordycepin and underlying mechanism on the sepsis. METHODS: The sepsis mice model was built and treated with different concentrations of cordycepin. Then the liver and lung injury caused by cecal ligation and puncture (CLP) was assessed using H&E staining and TUNEL assay. The expression of relevant genes was detected using qRT-PCR analysis and ELISA assays. Besides, the macrophage polarization was checked by flow cytometry. KEY FINDINGS: Cordycepin could significantly improve the liver and lung injury. Moreover, cordycepin increased the distribution of F4/80+ CD206+ M2-like macrophages and F4/80+ iNOS+ M1-like macrophages through down-regulating the expression of relevant genes. More importantly, cordycepin could monitor the protein expression of iNOS, Arg-1, TNF-α, MCP-1, IL-4 and IL-10 in CLP mice. Meanwhile, the elevated level of p65 induced by CLP was also repressed by the increase of the cordycepin. Moreover, cordycepin played a crucial part in CLP mice through modulating the NF-κB/p65 signalling pathway. CONCLUSIONS: Cordycepin played an important role in mice with sepsis via reducing the M1/M2 macrophage polarization and modulating the NF-κB/p65 signalling pathway.
21
Nuclear Factor-κB Contributes to Infarction After Permanent Focal Ischemia
Antti Nurmi, Perttu J. Lindsberg, Milla Koistinaho et al. · Stroke · 2004 · 290 citations · Full text
Lauren J. Simmons, Monique C. Surles-Zeigler, Yonggang Li et al. · Journal of Neuroinflammation · 2016 · 159 citations · Full text
Ser276 Phosphorylation of NF-kB p65 by MSK1 Controls SCF Expression in Inflammation
Laurent L. Reber, Linda Vermeulen, Guy Haegeman et al. · PLoS ONE · 2009 · 152 citations · Full text